Get the Stockscreener App
2.40
4.00%
-0.10
Arca Biopharma Inc Stock (ABIO) Forecast
The Arca Biopharma Inc (ABIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.203, representing a +33.46% increase from the current price of $2.40. The highest analyst price target is $3.0353, and the lowest is $3.3707.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ABIO Price Target
Average 7.2323
(+201.35% Upside)
Is Arca Biopharma Inc (ABIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.32 | Neutral |
| STOCH(9,6) | 53.26 | Neutral |
| STOCHRSI(14) | 1.4809 | Buy |
| MACD(12,26) | -0.00656 | Sell |
| ADX(14) | 25.15 | Sell |
| William %R | -76.86 | Neutral |
| CCI(14) | -117.97 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.528
Sell
|
3.2218
Sell
|
| MA20 |
3.1838
Sell
|
3.2497
Sell
|
| MA50 |
3.2896
Sell
|
3.2397
Sell
|
| MA100 |
3.3333
Sell
|
3.1028
Sell
|
| MA200 |
2.5555
Sell
|
2.6477
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ABIO could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 13 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on ABIO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.32 indicates that ABIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.26 indicates that ABIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.4809 indicates that ABIO is oversold. This suggests that ABIO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.15 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -117.97 indicates that ABIO is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ABIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arca Biopharma Inc financial reports and earnings history, Arca Biopharma Inc (ABIO) stock could reach $12.71 by 2030, $10.25 by 2040 and $26.74 by 2050. See the projected annual prices until 2050 of the Arca Biopharma Inc stock below:
- Arca Biopharma Inc (ABIO) is expected to reach an average price of $4.3632 in 2035, with a high prediction of $4.631 and a low estimate of $4.5332. This indicates an $81.80% rise from the last recorded price of $2.40.
- Arca Biopharma Inc (ABIO) stock is projected to chart a bullish course in 2040, with an average price target of $10.06, representing an $318.99% surge from its current level. The forecast ranges from a conservative $10.13 to a sky-high $10.25.
- Our analysts predict Arca Biopharma Inc (ABIO) to jump 622.94% by 2045, soaring from $17.36 to an average price of $17.35, potentially reaching $17.37. While $17.36 is the low estimate, the potential upside is significant.
- Arca Biopharma Inc (ABIO) stock is expected to climb by 2050, reaching an average of $25.97, a $982.03% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.74 and $26.38, respectively, highlighting the market's uncertainty.
Arca Biopharma Inc Stock (ABIO) Year by Year Forecast
Arca Biopharma Inc Stock (ABIO) Price Forecast for 2025
Arca Biopharma Inc Stock (ABIO) is expected to reach an average price of $7.2323 in 2025, with a high prediction of $13.65 and a low estimate of $0.8183. This indicates an +201.35% rise from the last recorded price of $2.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $3.5932 | $3.3707 | $3.0353 | +49.72% |
| March, 2025 | $5.0839 | $3.5146 | $4.2294 | +111.83% |
| April, 2025 | $5.8182 | $5.2886 | $5.9479 | +142.42% |
| May, 2025 | $4.2058 | $4.4057 | $5.7118 | +75.24% |
| June, 2025 | $4.6344 | $4.8597 | $4.787 | +93.10% |
| July, 2025 | $1.4276 | $0.8183 | $13.65 | -40.52% |
| August, 2025 | $1.5862 | $1.5723 | $1.3216 | -33.91% |
| September, 2025 | $1.1948 | $1.4601 | $1.0855 | -50.22% |
| October, 2025 | $3.538 | $2.1894 | $2.518 | +47.42% |
| November, 2025 | $3.4266 | $3.4484 | $3.2438 | +42.78% |
| December, 2025 | $3.8699 | $3.5359 | $3.5999 | +61.24% |
Arca Biopharma Inc Stock (ABIO) Price Forecast for 2026
The predicted value for Arca Biopharma Inc (ABIO) in 2026 is set at an average of $3.1166. Estimates vary from a peak of $3.6391 to a trough of $2.5942, indicating an +29.86% surge from the present price of $2.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.3385 | $3.7084 | $3.5792 | +39.10% |
| February, 2026 | $3.5071 | $3.4678 | $3.3231 | +46.13% |
| March, 2026 | $2.9657 | $3.2157 | $3.1462 | +23.57% |
| April, 2026 | $2.5389 | $2.5942 | $2.6376 | +5.79% |
| May, 2026 | $3.0075 | $3.1435 | $2.8537 | +25.31% |
| June, 2026 | $3.4561 | $3.4464 | $3.4218 | +44.00% |
| July, 2026 | $3.7293 | $3.5902 | $3.5299 | +55.39% |
| August, 2026 | $3.1779 | $3.2779 | $3.514 | +32.41% |
| September, 2026 | $3.0512 | $3.2326 | $3.2065 | +27.13% |
| October, 2026 | $3.5198 | $3.7298 | $3.4605 | +46.66% |
| November, 2026 | $3.4384 | $3.5284 | $3.6391 | +43.26% |
| December, 2026 | $3.4416 | $3.467 | $3.4016 | +43.40% |
Arca Biopharma Inc Stock (ABIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arca Biopharma Inc (ABIO) is $3.3547, with a high forecast of $3.9646 and a low forecast of $2.7447. This indicates an +39.78% increase from the last price of $2.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.6402 | $3.4762 | $3.4702 | +51.67% |
| February, 2027 | $3.8388 | $3.6595 | $3.7088 | +59.95% |
| March, 2027 | $3.702 | $3.8381 | $3.7027 | +54.25% |
| April, 2027 | $3.9506 | $3.8017 | $3.8306 | +64.61% |
| May, 2027 | $4.0092 | $4.0689 | $3.9646 | +67.05% |
| June, 2027 | $3.7025 | $3.7878 | $3.8585 | +54.27% |
| July, 2027 | $3.3411 | $3.3815 | $3.4871 | +39.21% |
| August, 2027 | $3.2197 | $3.2397 | $3.3657 | +34.15% |
| September, 2027 | $2.9929 | $3.1629 | $3.0782 | +24.70% |
| October, 2027 | $2.9615 | $3.0262 | $2.9675 | +23.40% |
| November, 2027 | $2.7001 | $2.8353 | $2.7454 | +12.50% |
| December, 2027 | $2.6133 | $2.7447 | $2.6694 | +8.89% |
Arca Biopharma Inc Stock (ABIO) Price Forecast for 2028
In 2028, Arca Biopharma Inc (ABIO) is projected to reach an average price of $2.2451, with a high projection of $2.7298 and a low estimate of $1.7604. This indicates an -6.45% fall from the last price of $2.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6319 | $2.6719 | $2.6319 | +9.66% |
| February, 2028 | $2.8205 | $2.6812 | $2.7278 | +17.52% |
| March, 2028 | $2.6038 | $2.6338 | $2.7298 | +8.49% |
| April, 2028 | $2.5724 | $2.6524 | $2.5977 | +7.18% |
| May, 2028 | $2.1756 | $2.2556 | $2.517 | -9.35% |
| June, 2028 | $2.1243 | $2.1495 | $2.0702 | -11.49% |
| July, 2028 | $2.2728 | $2.1581 | $2.1135 | -5.30% |
| August, 2028 | $2.016 | $2.076 | $2.1221 | -16.00% |
| September, 2028 | $2.1246 | $2.1207 | $2.0646 | -11.47% |
| October, 2028 | $1.8837 | $2.0332 | $2.0193 | -21.51% |
| November, 2028 | $1.7565 | $1.8565 | $1.8579 | -26.81% |
| December, 2028 | $1.735 | $1.7604 | $1.7311 | -27.71% |
Arca Biopharma Inc Stock (ABIO) Price Forecast for 2029
The 2029 price forecast for Arca Biopharma Inc Stock (ABIO) is $1.7933 on average, with a high prediction of $3.2102 and a low estimate of $0.3765. This represents an -25.28% decrease from the previous price of $2.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.5983 | $1.6033 | $1.6597 | -33.40% |
| February, 2029 | $1.4869 | $1.5269 | $1.5629 | -38.05% |
| March, 2029 | $1.3855 | $1.4255 | $1.4415 | -42.27% |
| April, 2029 | $1.2991 | $1.3241 | $1.3501 | -45.87% |
| May, 2029 | $1.4145 | $1.3087 | $1.373 | -41.06% |
| June, 2029 | $1.2759 | $1.2912 | $1.362 | -46.84% |
| July, 2029 | $1.3045 | $1.3006 | $1.2545 | -45.65% |
| August, 2029 | $1.2877 | $1.3077 | $1.2785 | -46.34% |
| September, 2029 | $1.1463 | $1.2017 | $1.2024 | -52.24% |
| October, 2029 | $0.8796 | $0.9996 | $1.0356 | -63.35% |
| November, 2029 | $0.8518 | $0.3765 | $1.2811 | -64.51% |
| December, 2029 | $6.6501 | $0.7079 | $3.2102 | +177.09% |
Arca Biopharma Inc Stock (ABIO) Price Forecast for 2030
Arca Biopharma Inc Stock (ABIO) is expected to reach an average price of $12.68 in 2030, with a high forecast of $14.61 and a low forecast of $10.75. This signifies an +428.23% surge from the last price of $2.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.11 | $10.75 | $12.71 | +446.16% |
| February, 2030 | $12.44 | $12.52 | $12.52 | +418.49% |
| March, 2030 | $12.85 | $12.52 | $12.24 | +435.46% |
| April, 2030 | $13.43 | $13.24 | $13.19 | +459.72% |
| May, 2030 | $13.36 | $13.28 | $13.27 | +456.86% |
| June, 2030 | $13.15 | $13.35 | $13.16 | +448.00% |
| July, 2030 | $12.98 | $13.10 | $13.12 | +440.77% |
| August, 2030 | $12.33 | $12.83 | $12.53 | +413.57% |
| September, 2030 | $11.53 | $12.34 | $12.15 | +380.60% |
| October, 2030 | $12.09 | $12.23 | $11.87 | +403.72% |
| November, 2030 | $14.66 | $13.58 | $13.39 | +510.69% |
| December, 2030 | $14.32 | $14.55 | $14.61 | +496.82% |
3.54%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):